Zomedica Corp.

AMEX: ZOM · Real-Time Price · USD
0.10
0.00 (2.56%)
At close: Mar 04, 2025, 9:50 AM

Zomedica Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Revenue
25.19M 18.93M 4.13M n/a
Cost of Revenue
7.87M 5.28M 1.08M 530.02K
Gross Profit
17.32M 13.65M 3.05M -530.02K
Operating Income
-31.59M -21.92M -21.37M -16.76M
Interest Income
5.46M 2.7M 357.45K 32.86K
Pretax Income
-35.86M -19.38M -20.72M -16.91M
Net Income
-34.53M -17.02M -18.38M -16.92M
Selling & General & Admin
43.17M 33M 22.75M 8.19M
Research & Development
5.74M 2.58M 1.67M 8.04M
Other Expenses
n/a -7K 6K 530.02K
Operating Expenses
48.91M 35.58M 24.43M 16.76M
Interest Expense
175K 1K 6.05K 732.00
Selling & Marketing Expenses
14.14M 9.88M n/a 261.91K
Cost & Expenses
56.78M 40.85M 25.51M 16.76M
Income Tax Expense
-1.33M -2.37M -2.33M 9.33K
Shares Outstanding (Basic)
979.95M 979.92M 956.53M 364.44M
Shares Outstanding (Diluted)
979.95M 979.92M 956.53M 364.44M
EPS (Basic)
-0.04 -0.02 -0.02 -0.05
EPS (Diluted)
-0.04 -0.02 -0.02 -0.05
EBITDA
-29.39M -15.34M -19.57M -16.38M
EBIT
-35.69M -19.38M -20.71M -16.91M
Depreciation & Amortization
6.3M 4.04M 1.14M 530.02K